SCHEMBL997788

SCHEMBL997788

COC(=O)c1n[nH]c2cc(C(F)F)cc(Cc3ccc(Cl)cc3Cl)c12

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALPL P05186 1/20 0.39
▸ NPSR1 Q6W5P4 2/20 0.39
▸ HPGD P15428 1/20 0.39
▸ MAP2K4 P45985 1/20 0.38
▸ P2RX7 Q99572 1/20 0.38
▸ GSK3B P49841 1/20 0.38
▸ GAA P10253 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ S1PR4 O95977 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ STAT3 P40763 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ TRPV1 Q8NER1 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ LMNA P02545 1/20 0.35
▸ HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL998544 0.83 KDM4E (0.45) ALPLNPSR1HPGDMAP2K4P2RX7
SCHEMBL997498 0.75 KDM4E (0.43) NPSR1HPGDMAP2K4P2RX7ALDH1A1
SCHEMBL998780 0.75 KDM4E (0.43) MAP2K4GSK3BSMN1; SMN2KDM4ESTAT3
SCHEMBL5023203 0.69 TBXA2R (0.45) ALPLNPSR1P2RX7GSK3BHIF1A
SCHEMBL27956837 0.69 KDM4E (0.58) MAP2K4ALDH1A1SMN1; SMN2KDM4ESTAT3
SCHEMBL30609861 0.67 MAP2K4 (0.65) ALPLMAP2K4GSK3BSMN1; SMN2KDM4E
SCHEMBL4793264 0.67 KDM4E (0.63) ALPLHPGDMAP2K4ALDH1A1SMN1; SMN2
SCHEMBL4791992 0.67 MAP2K4 (0.65) ALPLMAP2K4GSK3BSMN1; SMN2KDM4E
SCHEMBL4109673 0.67 CYP1A2 (0.53) NPSR1ALDH1A1SMN1; SMN2HIF1ACYP3A4
SCHEMBL5267750 0.66 NR2E1 (0.37) NPSR1HPGDP2RX7GSK3BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786424-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT The University of Kansas (US) 2007-05-23 — — EP claimed
WO-2006023704-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT UNIVERSITY OF KANSAS (US) 2006-03-02 — — WO claimed
EP-2451783-A2 LONIDAMINE ANALOGUES FOR FERTILITY MANAGEMENT University Of Kansas (US) 2012-05-16 — — EP disclosed
WO-2011005759-A2 LONIDAMINE ANALOGUES FOR FERTILITY MANAGEMENT UNIVERSITY OF KANSAS (US) 2011-01-13 — — WO disclosed
Send feedback